AstraZeneca Pharma India plans a final dividend of Rs. 32 per equity share (face value Rs. 2) for FY 2024-25, pending shareholder approval at the upcoming AGM.

AstraZeneca Pharma India LimitedASTRAZEN · Filed with the exchange

If approved, shareholders will receive the payout within 30 days post-AGM, offering a solid cash return on investment.

No comments yet. Be the first.

More from AstraZeneca Pharma India Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.